Reported Tuberculosis in the United States, 2019

Return to Main Menu

List of All Tables

Executive Commentary

Executive Commentary

Tables

Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates per 100,000 Population, and Percent Change: United States, 1953–2019
Table 2. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Hispanic Ethnicity and Non-Hispanic Race: United States, 1993–2019
Table 3. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race, and by Origin of Birth: United States, 1993–2019
Table 4. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age Group: United States, 1993–2019
Table 5. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin of Birth: United States, 1993–2019
Table 6A. Tuberculosis Cases and Percentages among Non-U.S.–Born Persons by the Top 30 Countries of Birth: United States, 2015–2019
Table 6B. Tuberculosis Rates per 100,000 Population by Country of Birth in the United States by the Top 10 Countries of Birth: United States, 2015–2019
Table 7. Tuberculosis Cases and Percentages by Case Verification Criterion and Site of Disease: United States, 1993–2019
Table 8. Tuberculosis Cases and Percentages, by Resistance to Isoniazid (INH), Origin of Birth, and Previous History of TB: United States, 1993–2019
Table 9. Tuberculosis Cases and Percentages, by Multidrug Resistance (MDR), Origin of Birth, and Previous History of TB: United States, 1993–2019
Table 10. Percentages of Tuberculosis Cases, by Initial Drug Regimen, Use of Directly Observed Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2019
Table 11. Tuberculosis Cases and Percentages among Persons with HIV Test Results and with HIV Coinfection, by Age Group: United States, 2011–2019
Table 12. Tuberculosis Cases and Percentages, by Reason Tuberculosis Therapy Was Stopped: United States, 1993–2017
Table 13. Deaths among Reported Tuberculosis Cases: United States, 2010–2017
Table 14. Sputum Culture Conversion: United States, 2010–2017
Table 15. Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease: United States, 2010–2019
Table 16. National Tuberculosis Genotyping Surveillance Coverage: United States, 2004–2019
Table 17. National Tuberculosis Genotyping Surveillance Coverage: United States-Affiliated Areas, 2004–2019
Table 18. Genotyped Tuberculosis Cases with Mycobacterium bovis by Origin of Birth: United States, 2004–2019
Table 19. Tuberculosis Cases and Percentages among Non-U.S.–Born Persons, by the Top 30 Countries of Birth and Years in the United States before TB Diagnosis: United States, 2019
Table 20. Tuberculosis Cases and Rates per 100,000 Population, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2019
Table 21. Tuberculosis Cases among U.S.-Born Persons, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2019
Table 22. Tuberculosis Cases among Non-U.S.–Born Persons, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2019
Table 23. Tuberculosis Risk Factors, by Origin and Race/Ethnicity: United States, 2019
Table 24. Characteristics of Tuberculosis Cases in GENType Clusters, by Alert Levels Based on Log-Likelihood Ratios (LLR): United States, 2017–2019
Table 25. Tuberculosis Cases and Clusters, by Cluster Size: United States, 2017–2019
Table 26. Twenty-Five Most Frequently Reported GENTypes among Genotyped Tuberculosis Cases: United States, 2017–2019
Table 27. Five Most Frequently Reported GENTypes Among Genotyped Tuberculosis Cases: United States-Affiliated Areas, 2017–2019
Table 28. Tuberculosis Cases and Case Rates per 100,000 Population: Reporting Areas, 2019 and 2018
Table 29. Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped by Number of Cases: United States and the District of Columbia, 2019 and 2018
Table 30. Tuberculosis Cases and Percentages, by Age Group: Reporting Areas, 2019
Table 31. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race: Reporting Areas, 2019
Table 32. Tuberculosis Cases and Percentages, U.S.-born and Non-U.S.–Born Persons: United States and the District of Columbia, 2019
Table 33. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by Number of Years in the United States: United States and the District of Columbia, 2019
Table 34. Tuberculosis Cases and Percentages, by Pulmonary and Extrapulmonary Disease: Reporting Areas, 2019
Table 35. Tuberculosis Risk Factors: Reporting Areas, 2019
Table 36. Primary Reason for Tuberculosis Evaluation: Reporting Areas, 2019
Table 37. Tuberculosis Cases and Percentages, by Residence in and Type of Correctional Facilities, Ages ≥15 Years: Reporting Areas, 2019
Table 38. Tuberculosis Cases and Percentages, by Homelessness Status, Ages ≥15 Years: Reporting Areas, 2019
Table 39. Tuberculosis Cases and Percentages, by Residence in Long–Term Care Facilities, Ages ≥15 Years: Reporting Areas, 2019
Table 40. Tuberculosis Cases and Percentages, by Injecting Drug Use, Ages ≥15 Years: Reporting Areas, 2019
Table 41. Tuberculosis Cases and Percentages, by Noninjecting Drug Use, Ages ≥15 Years: Reporting Areas, 2019
Table 42. Tuberculosis Cases and Percentages, by Excess Alcohol Use, Ages ≥15 Years: Reporting Areas, 2019
Table 43. Tuberculosis Cases and Percentages by Primary Occupation, Ages ≥15 Years: Reporting Areas, 2019
Table 44. Tuberculosis Cases and Percentages, by Initial Drug Regimen: Reporting Areas, 2019
Table 45. Culture-Positive Tuberculosis Cases and Percentages with Drug Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2019
Table 46. Tuberculosis Cases and Percentages, by HIV Status: Reporting Areas, 2019
Table 47. Tuberculosis Genotyping Surveillance Coverage: Reporting Areas, 2019
Table 48. Tuberculosis Cases and Percentages, by Directly Observed Therapy (DOT): Reporting Areas, 2017
Table 49. Tuberculosis Cases and Percentages, by Reason Therapy Was Stopped: Reporting Areas, 2017
Table 50. Reason Therapy Was Extended Beyond 12 Months: Reporting Areas, 2017
Table 51.Tuberculosis Cases and Percentages, by Completion of Tuberculosis Therapy (COT): Reporting Areas, 2017
Table 52. Tuberculosis Cases and Percentages among Persons Completing Therapy for Whom Therapy Was Indicated for ≤1 Year: Reporting Areas, 2013–2017
Table 53. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statistical Areas with ≥500,000 Population, 2019 and 2018
Table 54. Tuberculosis Cases, by Age Group: Metropolitan Statistical Areas with ≥500,000 Population, 2019
Table 55. Tuberculosis Cases, by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan Statistical Areas with ≥500,000 Population, 2019
Table 56.Tuberculosis Cases and Percentages, U.S.-Born Persons and Non-U.S.–Born Persons: Metropolitan Statistical Areas with ≥500,000 Population, 2019
Table 57. Counts and Percentages of Tuberculosis Cases Estimated to be Attributed to Recent Transmission and Extensive Recent Transmission: United States and the District of Columbia, 2018-2019
Table 58. Counts and Percentages of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: Counties with >5 Percent Estimated Extensive Recent Transmission, 2018-2019
Table 59. Characteristics of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: United States, 2018–2019

Figures

Figure 1. Estimated Cases Attributed to Recent Transmission of Tuberculosis, United States, 2018–2019
Figure 2. Estimated Percentage of Extensive Recent Transmission of Tuberculosis in Counties with 10 or More Genotyped Cases, United States, 2018–2019

Technical Notes

Technical Notes

Tuberculosis in the United States Slide Set

Tuberculosis in the United States Slide Set
Download complete set – (62 slides)
Slide Set Narrative
Archived Surveillance Slide Sets

Appendices

Acknowledgements
Appendix A: Tuberculosis Case Definition for Public Health Surveillance
Appendix B: Recommendations for Reporting and Counting Tuberculosis Cases
Appendix C: Genotyping Background Information & Glossary